[1]余 磊,唐 璠,曹志伟,等.经导管肾动脉栓塞术治疗常染色体显性遗传性多囊肾病并发血尿的效果和安全性[J].介入放射学杂志,2022,31(09):861-864.
 YU Lei,TANG Fan,CAO Zhiwei,et al.Transcatheter renal artery embolization for autosomal dominant polycystic kidney disease associated with hematuria: analysis of its efficacy and safety in 12 patents[J].journal interventional radiology,2022,31(09):861-864.
点击复制

经导管肾动脉栓塞术治疗常染色体显性遗传性多囊肾病并发血尿的效果和安全性()

PDF下载中关闭

分享到:

《介入放射学杂志》[ISSN:1008-794X/CN:31-1796/R]

卷:
31
期数:
2022年09
页码:
861-864
栏目:
血管介入
出版日期:
2022-10-13

文章信息/Info

Title:
Transcatheter renal artery embolization for autosomal dominant polycystic kidney disease associated with hematuria: analysis of its efficacy and safety in 12 patents
作者:
余 磊 唐 璠 曹志伟 张诚琮 苏孙欢 张起楷 肖玉玲
Author(s):
YU Lei TANG Fan CAO Zhiwei ZHANG Chengcong SU Sunhuan ZHANG Qikai XIAO Yuling.
Department of Interventional Radiology, Affiliated Sanming Municipal First Hospital of Fujian Medical University, Sanming, Fujian Province 365000, China
关键词:
【关键词】 经导管肾动脉栓塞术 常染色体显性遗传性多囊肾病 血尿 栓塞微球
文献标志码:
A
摘要:
【摘要】 目的 探讨经导管肾动脉栓塞术(TRAE)治疗常染色体显性遗传性多囊肾病(ADPKD)并发血尿的效果和安全性。方法 回顾性分析2010年1月至2018年12月三明市第一医院采用TRAE治疗的12例ADPKD并发血尿患者临床资料。采用粒径300~900 μm三丙烯明胶微粒球(Embosphere)行TRAE术,栓塞靶血管为肾动脉2级以下分支,栓塞终点为靶血管主干对比剂滞留。术中复查造影明确靶血管闭塞情况。观察住院期并发症发生情况,随访30 d内再出血率、肾脏总体积缩小率、血红蛋白升高率。结果 12例患者均成功实施TRAE术,技术成功率100%。术后3 d内11例患者血尿逐渐转清至消失,30 d内无再发血尿,1例90 d后再发血尿,经再次TRAE后血尿消失,止血成功率为91.66%。所有患者腹痛、腹胀较术前缓解,10例出现不同程度腰背部酸痛、低热,经止痛、退热、对症治疗3~5 d后症状消失,无异位栓塞、血管损伤等严重并发症发生。术后30 d内肾脏总体积与术前相比缩小30.47%(P<0.01),血红蛋白水平与术前相比上升22.81%(P<0.01)。结论 TRAE术治疗ADPKD并发血尿安全有效,远期疗效有待更多病例证实。

参考文献/References:

[1] Okyere P, Ephraim R, Okyere I, et al. Demographic, diagnostic and therapeutic characteristics of autosomal dominant polycystic kidney disease in Ghana[J]. BMC Nephrol, 2021, 22: 156.
[2] Bhasin B, Alzubaidi M, Velez J. Evaluation and management of gross hematuria in autosomal dominant polycystic kidney disease: a point of care guide for practicing internists[J]. Am J Med Sci, 2018, 356: 177- 180.
[3] Hajji M, Barbouch S, Harzallah A, et al. Clinical study on autosomal dominant polycystic kidney disease among North Tunisians[J]. Saudi J Kidney Dis Transpl, 2019, 30: 175- 184.
[4] Pelizzo G, Vallone MG, Milazzo M, et al. Renal angiomyolipo- matosis and bleeding aneurysms in a tuberous sclerosis context: selective artery embolization in a girl with end- stage renal failure[J]. Pediatr Rep, 2020, 12: 8352.
[5] Cheng C, Karvelas NB, Aronowitz P. Retroperitoneal cyst hemorrhage in polycystic kidney disease[J]. Cleve Clin J Med, 2015, 82: 20- 21.
[6] Horie S, Mochizuki T, Muto S,et al. Evidence- based clinical practic guidelines for polycystic kidney disease 2014[J]. Clin Exp Nephrol, 2016, 20: 493- 509.
[7] Lugo- Gavidia LM, Nolde JM, Kiuchi MG, et al. Interventional approaches for loin pain hematuria syndrome and kidney- related pain syndromes[J]. Curr Hypertens Rep, 2020, 22: 103.
[8] 张 翔,刘 丽,梁弦弦,等. 经皮肾穿刺活检术后出血介入栓塞治疗临床效果[J]. 介入放射学杂志, 2021, 30:79- 83.
[9] 李海涛,田书梅,张晓磷,等. 超选择肾动脉栓塞术治疗创伤性肾出血的中短期疗效[J]. 临床放射学杂志, 2014, 33:1583- 1586.
[10] 王承恩,范则杨,杨 敏,等. 超选择性肾动脉栓塞治疗巨大型肾血管平滑肌脂肪瘤[J]. 中国介入影像与治疗学, 2018, 15:327- 330.
[11] Hajjar K, Bou Chebl R, Kanso M, et al. Autosomal dominant polycystic kidney disease and minimal trauma: medical review and case report[J]. BMC Emerg Med, 2018, 18: 38.
[12] Ubara Y. New therapeutic option for autosomal dominant polycystic kidney disease patients with enlarged kidney and liver[J]. Ther Apher Dial, 2006, 10: 333- 341.
[13] Saljoghi R, Le Vourch A, Renard B, et al. Arterial embolization of polycystic kidneys as an alternative to ergonomic nephrectomy in renal pre- transplantation. Monocentric retrospective study[J]. Prog Urol, 2019, 29: 482- 489.
[14] Morishita H, Yamagami T, Takeuchi Y, et al. Use of N- butyl- 2- cyanoacrylate for transcatheter arterial embolization of renal arteries in patients with polycystic kidney disease[J]. J Vasc Interv Radiol, 2011, 22: 1631- 1633.
[15] 孟小茜,董伟华,王 智,等. 经肾动脉栓塞术对常染色体显性多囊肾病终末期的对症治疗[J]. 介入放射学杂志, 2013, 22:461- 463.
[16] Shimohira M, Nagai K, Ohta K, et al. Use of microspheres in embolization for unruptured renal angiomyolipomas[J]. Open Med(Wars), 2021, 16: 655- 659.

备注/Memo

备注/Memo:
(收稿日期:2021- 08- 22)
(本文编辑:边 佶)
更新日期/Last Update: 2022-10-11